Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could remote Check-Ups replace frequent hospital visits for cochlear implant patients?

NCT ID NCT07117968

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 28 times

Summary

This study tests a new care pathway for adults receiving a cochlear implant. Instead of the usual nine in-person visits in the first year, the new approach uses early activation of the implant and remote monitoring visits. The goal is to see if this flexible plan maintains hearing performance while improving quality of life and reducing the burden on patients and hospitals. About 130 participants will be randomly assigned to either standard care or the new hybrid pathway.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEAFNESS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

remote monitoring and early activation of cochlear implant

What this could lead to

If it works, this could make follow-up care after cochlear implant surgery more convenient and flexible, reducing the number of in-person visits while maintaining hearing performance.

What could go wrong

This is a non-inferiority trial, meaning it aims to show the new approach is not worse than standard care. It is still early, and the benefits may not be as strong as hoped. Remote monitoring may not suit all patients.

Conditions

The condition(s) this trial relates to.

Deafness hearing loss disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.